Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension

被引:141
|
作者
Hernanz, R. [1 ,2 ]
Martinez-Revelles, S. [2 ,3 ]
Palacios, R. [1 ,2 ]
Martin, A. [1 ,2 ]
Cachofeiro, V. [4 ]
Aguado, A. [2 ,3 ]
Garcia-Redondo, L. [2 ,3 ]
Barrus, M. T. [1 ]
de Batista, P. R. [1 ]
Briones, A. M. [2 ,3 ]
Salaices, M. [2 ,3 ]
Alonso, M. J. [1 ,2 ]
机构
[1] Univ Rey Juan Carlos, Dept Ciencias Basicas Salud, Alcorcon 28922, Spain
[2] Inst Invest Hosp Univ La Paz IdiPaz, Madrid, Spain
[3] Univ Autonoma Madrid, Dept Farmacol, Madrid, Spain
[4] Univ Complutense Madrid, Dept Fisiol, Madrid, Spain
关键词
EXTRACELLULAR-MATRIX; BLOOD-PRESSURE; SMOOTH-MUSCLE; CONCISE GUIDE; INFLAMMATION; PHARMACOLOGY; EXPRESSION; DISEASE; CYCLOOXYGENASE-2; INHIBITION;
D O I
10.1111/bph.13117
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and PurposeToll-like receptor 4 (TLR4) signalling contributes to inflammatory cardiovascular diseases, but its role in hypertension and the associated vascular damage is not known. We investigated whether TLR4 activation contributed to angiotensin II (AngII)-induced hypertension and the associated vascular structural, mechanical and functional alterations. Experimental ApproachAngII was infused (1.44mgkg(-1)day(-1), s.c.) for 2 weeks in C57BL6 mice, treated with a neutralizing anti-TLR4 antibody or IgG (1gday(-1)); systolic BP (SBP) and aortic cytokine levels were measured. Structural, mechanical and contractile properties of aortic and mesenteric arterial segments were measured with myography and histology. RT-PCR and Western blotting were used to analyse these tissues and cultured vascular smooth muscle cells (VSMC) from hypertensive rats (SHR). Key ResultsAortic TLR4 mRNA levels were raised by AngII infusion. Anti-TLR4 antibody treatment of AngII-treated mice normalised: (i) increased SBP and TNF-, IL-6 and CCL2 levels; (ii) vascular structural and mechanical changes; (iii) altered aortic phenylephrine- and ACh-induced responses; (iv) increased NOX-1 mRNA levels, superoxide anion production and NAD(P)H oxidase activity and effects of catalase, apocynin, ML-171 and Mito-TEMPO on vascular responses; and (v) reduced NO release and effects of L-NAME on phenylephrine-induced contraction. In VSMC, the MyD88 inhibitor ST-2825 reduced AngII-induced NAD(P)H oxidase activity. The TLR4 inhibitor CLI-095 reduced AngII-induced increased phospho-JNK1/2 and p65 NF-B subunit nuclear protein expression. Conclusions and ImplicationsTLR4 up-regulation by AngII contributed to the inflammation, endothelial dysfunction, vascular remodelling and stiffness associated with hypertension by mechanisms involving oxidative stress. MyD88-dependent activation and JNK/NF-B signalling pathways participated in these alterations.
引用
收藏
页码:3159 / 3176
页数:18
相关论文
共 50 条
  • [1] Toll-Like Receptor 4 Contributes to Hypertension and Endothelial Dysfunction Produced By Angiotensin II
    Palvia, Vijay
    Pyle, Chelsea
    Mezzetti, Erin
    Chen, Xunsheng
    Didion, Sean
    FASEB JOURNAL, 2012, 26
  • [2] Toll-like receptor is involved in cardiac dysfunction in angiotensin II-induced hypertension
    Matsuda, S. M.
    Umemoto, S. U.
    Yoshino, H. Y.
    Itoh, S. I.
    Aoki, H. A.
    Yoshimura, K. Y.
    Murata, T. M.
    Matsuzaki, M. M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 426 - 426
  • [3] Toll-Like Receptor 4 Upregulation by Angiotensin II Contributes to Hypertension and Vascular Dysfunction through Reactive Oxygen Species Production
    De Batista, Priscila R.
    Palacios, Roberto
    Martin, Angela
    Hernanz, Raquel
    Medici, Cindy T.
    Silva, Marito A. S. C.
    Rossi, Emilly M.
    Aguado, Andrea
    Vassallo, Dalton V.
    Salaices, Mercedes
    Alonso, Maria J.
    PLOS ONE, 2014, 9 (08):
  • [4] Toll-like receptor 4 selectively activates MCP-1 to induce cardiac hypertrophy and dysfunction in angiotensin II-induced hypertension
    Matsuda, S.
    Umemoto, S.
    Yoshino, H.
    Nakashima, T.
    Ito, S.
    Aoki, H.
    Yoshimura, K.
    Murata, T.
    Matsuzaki, M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 243 - 243
  • [5] Toll-like receptor 4 (TLR4) impairs nitric oxide contributing to Angiotensin II-induced cavernosal dysfunction
    Nunes, Kenia P.
    Bomfim, Gisele F.
    Toque, Haroldo A.
    Szasz, Theodora
    Webb, R. Clinton
    LIFE SCIENCES, 2017, 191 : 219 - 226
  • [6] TOLL-LIKE RECEPTOR 4 INCREASES OXIDATIVE STRESS BY INHIBITING EXTRACELLULAR SUPEROXIDE DISMUTASE IN ANGIOTENSIN II-INDUCED HYPERTENSION
    Yoshino, Hiroko
    Umemoto, Seiji
    Matsuda, Susumu
    Nakashima, Tadaaki
    Itoh, Shinichi
    Aoki, Hiroki
    Yoshimura, Koichi
    Murata, Tomoaki
    Fukai, Tohru
    Matsuzaki, Masunori
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 98 - 98
  • [7] TOLL-LIKE RECEPTOR 4 CONTRIBUTES TO VASCULAR DYSFUNCTION IN TRAUMA/HEMORRHAGIC SHOCK
    Mazor, Rafi
    Dos Santos, Fernando
    Li, Joyce B.
    Aletti, Federico
    Kistler, Erik B.
    SHOCK, 2020, 53 : 67 - 68
  • [8] Toll-like receptor 4 increases oxidative stress by inhibiting the upregulation of extracellular superoxide dismutase in angiotensin II-induced hypertension
    Yoshino, H.
    Umemoto, S.
    Matsuda, S.
    Nakashima, T.
    Itoh, S.
    Aoki, H.
    Yoshimura, K.
    Murata, T.
    Fukai, T.
    Matsuzaki, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 727 - 727
  • [9] Toll-Like Receptor 4 Upregulates Oxidative Stress by Inhibiting the Upregulation of Extracellular Superoxide Dismutase in Angiotensin II-Induced Hypertension
    Yoshino, Hiroko
    Umemoto, Seiji
    Ito, Shinichi
    Matsuda, Susumu
    Aoki, Hiroki
    Yoshimura, Koichi
    Murata, Tomoaki
    Matsuzaki, Masunori
    CIRCULATION, 2008, 118 (18) : S347 - S347
  • [10] Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis
    Fukuda, Daiju
    Nishimoto, Sachiko
    Aini, Kunduziayi
    Tanaka, Atsushi
    Nishiguchi, Tsuyoshi
    Kim-Kaneyama, Joo-ri
    Lei, Xiao-Feng
    Masuda, Kiyoshi
    Naruto, Takuya
    Tanaka, Kimie
    Higashikuni, Yasutomi
    Hirata, Yoichiro
    Yagi, Shusuke
    Kusunose, Kenya
    Yamada, Hirotsugu
    Soeki, Takeshi
    Imoto, Issei
    Akasaka, Takashi
    Shimabukuro, Michio
    Sata, Masataka
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (07):